eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 2 : 121-129 doi: ijmmas.2005.121.129
Research Article
Cytokine and Trophic Biology as Cellular Transcriptional Susceptibility in Neuronal Ischemia
Published
March 30, 2005
Abstract

Cytokines and neurotrophins appear to constitute a series of self-amplifying systems in the development of essential features of ischemic neuronal injury that morphologically distinguish it in terms of either necrosis or apoptosis. An interaction of regional components at the tissue and organ level would involve vessels and particularly endothelium that are associated with proliferating glia and injured groups of neurons. It is in terms of a system of progression as applicable to cytokine action, trophic biology and gene transcription pathways that one may account for the development of ischemia as a selective susceptibility of neurons. A primary neuronal pathobiology would evolve developmentally in terms of oxidative stress, nitric oxide production and Calcium ion influx and would be reflected in lowered pH of regional tissues. Pinpointing the time of death of cells might be translated in terms of cytokine and trophic effects that promote cytoskeletal injury in the face of energy depletion. Reperfusion and no-eflow phenomena would further reflect involvement of cytokines and neurotrophins in neuronal ischemia. In fact, capillary bed loss would eventually result in central core necrosis of focal ischemic lesions that contrasts with the surrounding potentially viable penumbral zone.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Internet of Medical Things in Healthcare Delivery: Transforming Modern Healthcare Through Connected Technologies
1-6
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Predictors of Acute Coronary Syndrome Outcomes: A Multicenter Evaluation of Clinical, Biochemical, and Demographic Risk Factors
11-15
Wearable Devices for Chronic Disease Monitoring: Transforming Healthcare Through Continuous Digital Health Surveillance
22-26
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.